Implantable device outsourcer Cirtec Medical recently announced that it will open a “neuromodular center of excellence” in a manufacturing plant near another of its facilities in Brooklyn Park, Minn.

The center will be housed in an 85,000 sq. ft. building that the company leased to manufacture active implantable devices and perform clean-room assembly of neuromodulation leads, implantable pulse generators and accessories. The new space will allow the company to expand its engineering capabilities in mechanical, process, quality, electrical engineering, software, firmware and testing. Other offerings will include silicone injection molding, plastic injection molding, final packaging and ethylene oxide sterilization.

Cirtec recently announced plans to build a 30,000 sq. ft. manufacturing plant in the Coyol Free Zone, located in Alajuela, Costa Rica. In 2017, Cirtec added 30,000 square feet to the 54,000-square-foot Brooklyn Park plant it acquired through its purchase of Stellar Technologies the previous year.

“This is an exciting time for Cirtec,” said company CEO Brian Highley in a news release. “However our continued growth has created some real challenges with space. The new site and the addition of our Costa Rica facility are a necessary part of ensuring we have the capacity to support our customer’s growth over the longer term.”

Construction on the new facility is expected to begin in the first quarter of 2020, with completion targeted in the second half of the year. The existing Brooklyn Park facility will become an all-metals component and sub-assemblies facility, focusing on Swiss machining, milling, stamping, coil winding, laser cutting and welding, and nitinol processing.